Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Acta cir. bras ; 35(3): e202000303, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1130621

RESUMEN

Abstract Purpose: To evaluate the in vivo response of photobiomodulation therapy associated with norbixin-based poly(hydroxybutyrate) membrane (PHB) in tenotomized calcaneal tendon. Methods: Thirty rats were randomly allocated to six groups (n=5 each): LED groups (L1, L2 and L3) and membrane + LED groups (ML1, ML2 and ML3). The right calcaneal tendons of all animals were sectioned transversely and were irradiated with LED daily, one hour after surgery every 24 hours, until the day of euthanasia. At the end of the experiments the tendons were removed for histological analysis. Results: The histological analysis showed a significant reduction in inflammatory cells in the ML1, ML2 and ML3 groups (p=0.0056, p=0.0018 and p<0.0001, respectively) compared to those in the LED group. There was greater proliferation of fibroblasts in the ML1 (p<0.0001) and L3 (p<0.0001) groups. A higher concentration of type I collagen was also observed in the ML1 group (p=0.0043) replacing type III collagen. Conclusion: Photobiomodulation in association with norbixin-based PHB membrane led to control of the inflammatory process. However, it did not favor fibroblast proliferation and did not optimize type I collagen formation in the expected stage of the repair process.


Asunto(s)
Animales , Masculino , Ratas , Tendón Calcáneo/efectos de la radiación , Carotenoides/farmacología , Terapia por Luz de Baja Intensidad/métodos , Tendinopatía/radioterapia , Tenotomía/métodos , Hidroxibutiratos/farmacología , Tendón Calcáneo/cirugía , Tendón Calcáneo/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/efectos de la radiación , Distribución Aleatoria , Colágeno/farmacología , Ratas Wistar , Colágeno Tipo I/análisis , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo III/análisis , Colágeno Tipo III/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Fibroblastos/efectos de los fármacos , Fibroblastos/química , Prohibitinas
2.
Acta cir. bras ; 34(11): e201901101, Nov. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1054681

RESUMEN

Abstract Purpose: To determine the efficacy of norbixin-based poly(hydroxybutyrate) (PHB) membranes for Achilles tendon repair. Methods: Thirty rats were submitted to total tenotomy surgery of the right Achilles tendon and divided into two groups (control and membrane; n = 15 each), which were further subdivided into three subgroups (days 7, 14, and 21; n = 5 each). Samples were analyzed histologically. Results: Histological analysis showed a significant reduction in inflammatory infiltrates on days 7, 14 (p < 0.0001 for both), and 21 (p = 0.0004) in the membrane group compared to that in the control group. There was also a significant decrease in the number of fibroblasts in the control group on days 7, 14 (p < 0.0001), and 21 (p = 0.0032). Further, an increase in type I collagen deposition was observed in the membrane group compared to that in the control group on days 7 (p = 0.0133) and 14 (p = 0.0107). Conclusion: Treatment with norbixin-based PHB membranes reduces the inflammatory response, increases fibroblast proliferation, and improves collagen production in the tendon repair region, especially between days 7 and 14.


Asunto(s)
Humanos , Animales , Masculino , Poliésteres/farmacología , Tendón Calcáneo/cirugía , Tendón Calcáneo/efectos de los fármacos , Carotenoides/farmacología , Tenotomía/métodos , Hidroxibutiratos/farmacología , Valores de Referencia , Regeneración/efectos de los fármacos , Tendón Calcáneo/patología , Reproducibilidad de los Resultados , Ratas Wistar , Colágeno Tipo I/análisis , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo III/análisis , Colágeno Tipo III/efectos de los fármacos , Fibroblastos/efectos de los fármacos
3.
Braz. j. med. biol. res ; 52(11): e8772, 2019. graf
Artículo en Inglés | LILACS | ID: biblio-1039259

RESUMEN

This study aimed to investigate the mechanism of fluorofenidone (AKF-PD) in treating renal interstitial fibrosis in rats with unilateral urinary obstruction (UUO). Thirty-two male Sprague-Dawley rats were randomly divided into sham, UUO, UUO + enalapril, and UUO + AKF-PD groups. All rats, except sham, underwent left urethral obstruction surgery to establish the animal model. Rats were sacrificed 14 days after surgery, and serum was collected for renal function examination. Kidneys were collected to observe pathological changes. Immunohistochemistry was performed to assess collagen I (Col I) protein expression, and terminal deoxynucleotidyl transferase-mediated nick end-labeling staining to observe the apoptosis of renal tubular epithelial cells. The expression of Fas-associated death domain (FADD), apoptotic protease activating factor-1 (Apaf-1), and C/EBP homologous protein (CHOP) proteins was evaluated by immunohistochemistry and western blot analysis. AKF-PD showed no significant effect on renal function in UUO rats. The pathological changes were alleviated significantly after enalapril or AKF-PD treatment, but with no significant differences between the two groups. Col I protein was overexpressed in the UUO group, which was inhibited by both enalapril and AKF-PD. The number of apoptotic renal tubular epithelial cells was much higher in the UUO group, and AKF-PD significantly inhibited epithelial cells apoptosis. The expression of FADD, Apaf-1, and CHOP proteins was significantly upregulated in the UUO group and downregulated by enalapril and AKF-PD. In conclusion, AKF-PD improved renal interstitial fibrosis by inhibiting apoptosis of renal tubular epithelial cells in rats with UUO.


Asunto(s)
Animales , Masculino , Piridonas/farmacología , Obstrucción Ureteral/patología , Apoptosis/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Enfermedades Renales/patología , Piridonas/metabolismo , Nitrógeno de la Urea Sanguínea , Fibrosis , Inhibidores de la Enzima Convertidora de Angiotensina/metabolismo , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Enalapril/metabolismo , Enalapril/farmacología , Distribución Aleatoria , Ratas Sprague-Dawley , Creatinina/sangre , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo I/metabolismo , Modelos Animales de Enfermedad , Factor de Transcripción CHOP/efectos de los fármacos , Factor Apoptótico 1 Activador de Proteasas/efectos de los fármacos , Factor Apoptótico 1 Activador de Proteasas/metabolismo , Proteína de Dominio de Muerte Asociada a Fas/efectos de los fármacos , Proteína de Dominio de Muerte Asociada a Fas/metabolismo
4.
Pesqui. vet. bras ; 36(12): 1221-1226, Dec. 2016. tab, ilus
Artículo en Inglés | LILACS, VETINDEX | ID: biblio-842029

RESUMEN

Collagen plays essential roles in remodeling uterine tissue during decidualization, implantation, pregnancy and involution. To understand whether the progestational agent medroxyprogesterone acetate (MPA) can modify the organization and deposit of collagen in the uteri of normal bitches (Canis Tlupus familiaris), we assessed uterine tissues by histochemistry. Uteri were grouped as: nulliparous (n=11), multiparous (n=11) and treated with MPA (n=11; nulliparous with two treatments; 5mg/kg; i.m.). The amount, location and birefringence of interstitial collagen types I and III in the fold and base of the endometrial stroma and the myometrial muscular layers were studied on sections stained with Picrosirius Red by polarized light microscopy and evaluated by ANOVA. No differences were observed in the endometrium. In the myometrium, differences were observed in collagen type I between MPA-treated and nulliparous uteri vs. multiparous (p<0.05), and differences in collagen type III between nulliparous and multiparous uteri vs. MPA-treated (p=0.0001). In conclusion, two doses of MPA had no significant effect on the investigated collagens in the extracellular matrix.(AU)


Asunto(s)
Animales , Femenino , Perros , Colágeno Tipo III/efectos de los fármacos , Colágeno Tipo I/efectos de los fármacos , Acetato de Medroxiprogesterona/efectos adversos , Útero/anatomía & histología , Anticonceptivos/análisis , Colágenos Fibrilares
5.
Gut and Liver ; : 101-108, 2016.
Artículo en Inglés | WPRIM | ID: wpr-111611

RESUMEN

BACKGROUND/AIMS: The development of therapeutic strategies for the treatment of cirrhosis has become an important focus for basic and clinical researchers. Adrenergic receptor antagonists have been evaluated as antifibrotic drugs in rodent models of carbon tetrachloride (CCl4)-induced cirrhosis. The aim of the present study was to evaluate the effects of carvedilol and doxazosin on fibrosis/cirrhosis in a hamster animal model. METHODS: Cirrhotic-induced hamsters were treated by daily administration of carvedilol and doxazosin for 6 weeks. Hepatic function and histological evaluation were conducted by measuring biochemical markers, including total bilirubin, aspartate aminotransferase, alanine aminotransferase and albumin, and liver tissue slices. Additionally, transforming growth factor beta (TGF-beta) immunohistochemistry was analyzed. RESULTS: Biochemical markers revealed that hepatic function was restored after treatment with doxazosin and carvedilol. Histological evaluation showed a decrease in collagen type I deposits and TGF-beta-secreting cells. CONCLUSIONS: Taken together, these results suggest that the decrease in collagen type I following treatment with doxazosin or carvedilol is achieved by decreasing the profibrotic activities of TGF-beta via the blockage of alpha1- and beta-adrenergic receptor. Consequently, a diminution of fibrotic tissue in the CCl4-induced model of cirrhosis is achieved.


Asunto(s)
Animales , Cricetinae , Antagonistas de Receptores Adrenérgicos alfa 1/farmacología , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Bilirrubina/sangre , Carbazoles/farmacología , Tetracloruro de Carbono , Colágeno Tipo I/efectos de los fármacos , Doxazosina/farmacología , Hígado/metabolismo , Cirrosis Hepática/sangre , Pruebas de Función Hepática , Propanolaminas/farmacología , Albúmina Sérica/análisis , Factor de Crecimiento Transformador beta/sangre
6.
Acta cir. bras ; 30(1): 24-33, 01/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-735711

RESUMEN

PURPOSE: To evaluate the effect of propranolol on capsular architecture around silicone implants by measuring the inflammation, capsular thickness, and collagen fiber density, using a guinea pig experimental model. METHODS: Thirty six adult male guinea pigs randomly divided into two groups (n=18) were used. Each one received a silicone implant with textured-surface. The capsular tissue around implants from untreated or treated animals with the beta-adrenoceptor antagonist propranolol (10 mg/kg, dissolved in daily water) were analyzed for inflammation by histological scoring, capsular thickness by computerized histometry, and collagen fibers type I and Type III density by picrosirius polarization at different time points (7, 14 or 21 days after silicone implantation). RESULTS: Propranolol treatment reduced inflammation and impaired capsular thickness and delayed collagen maturation around the textured implant. CONCLUSION: Propranolol reduces the risk of developing capsular contracture around silicone implants with textured surface. .


Asunto(s)
Animales , Cobayas , Humanos , Masculino , Antagonistas Adrenérgicos beta/farmacología , Contractura Capsular en Implantes/prevención & control , Propranolol/farmacología , Geles de Silicona/efectos adversos , Antagonistas Adrenérgicos beta/uso terapéutico , Implantes de Mama/efectos adversos , Colágeno Tipo I/análisis , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo III/análisis , Colágeno Tipo III/efectos de los fármacos , Modelos Animales de Enfermedad , Contractura Capsular en Implantes/patología , Implantes Experimentales/efectos adversos , Propranolol/uso terapéutico , Distribución Aleatoria , Reproducibilidad de los Resultados , Tejido Subcutáneo/efectos de los fármacos , Tejido Subcutáneo/patología , Factores de Tiempo , Resultado del Tratamiento
7.
Int. braz. j. urol ; 40(2): 257-265, Mar-Apr/2014. graf
Artículo en Inglés | LILACS | ID: lil-711695

RESUMEN

PurposeTo evaluate the synthesis of type I (mature) and type III (immature) collagen in bladder suture of rats treated with a combination of tacrolimus and mycophenolate mofetil for 15 days.Materials and MethodsThirty rats were divided into 3 groups: the sham, control and experimental groups. All the animals underwent laparotomy, cystotomy and bladder suture in two planes with surgical PDS 5-0 thread. The sham group did not receive treatment. The control group received saline solution, and the experimental group received 0.1mg/kg/day of tacrolimus with 20mg/kg/day of mycophenolate mofetil, for 15 days. From then on, the tacrolimus was dosed. The surgical specimens of the bladder suture area were processed so that the total type I and type III collagen could be measured by the picrosirius red technique.ResultsThere was a predominance of type I collagen production in the sham and control groups compared to the experimental group, in which type III collagen was predominant. The production of total collagen did not change.ConclusionThe association of tacrolimus and mycophenolate mofetil in animals qualitatively changes the production of collagen after 15 days with a predominance of type III collagen.


Asunto(s)
Animales , Colágeno Tipo I/biosíntesis , Colágeno Tipo III/biosíntesis , Inmunosupresores/uso terapéutico , Ácido Micofenólico/análogos & derivados , Suturas , Tacrolimus/uso terapéutico , Vejiga Urinaria/cirugía , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo III/efectos de los fármacos , Ácido Micofenólico/uso terapéutico , Ratas Wistar , Reproducibilidad de los Resultados , Técnicas de Sutura , Resultado del Tratamiento , Cicatrización de Heridas/efectos de los fármacos
8.
Arq. bras. oftalmol ; 74(5): 348-351, set.-out. 2011. ilus
Artículo en Inglés | LILACS | ID: lil-608407

RESUMEN

PURPOSE: To determine if the corneal epithelium prevents the collagen cross-linking effect. Using immunofluorescence microscopy after CXL, we indirectly analyzed the role of the epithelium as ultraviolet-A (UVA) shield as well as a barrier to riboflavin penetration. METHODS: Fifteen freshly enucleated porcine eyes were divided into 3 groups. The corneal epithelium was kept intact in all groups. Five eyes served as control (Group 1). On group 2, eyes received tetracaine anesthetic drops and topical 0.1 percent riboflavin solution (10 mg riboflavin-5-phosphate in 10 mL 20 percent dextran-T-500). On Group 3, riboflavin was injected into the anterior chamber to allow penetration of the drug through the endothelium. Groups 2 and 3 were exposed to UVA (365 nm, 3 mW/cm²) for 30 minutes. Ultra-thin sections (8 µm) of the corneas were stained with anti-collagen type I and DAPI (4,6-diamidino-2-fenilindole dihydrocloride) and analyzed with fluorescence microscopy. RESULTS: Corneas treated with UVA irradiation and intracameral injection of riboflavin (Group 3) showed greater pattern of collagen organization compared to groups 1 (Control) and 2 (riboflavin and tetracaine eye drops). A yellow stromal staining, which represents the riboflavin diffusion into the stroma, was only observed in eyes injected with riboflavin into the anterior chamber. CONCLUSION: Using immunofluorescence microscopy in porcine corneas, we demonstrated that the corneal epithelium reduces the effectiveness of CXL by preventing the penetration of the drug and not by limiting the UVA transmittance. An inadequate intrastromal concentration of riboflavin may impair CXL effect.


OBJETIVO: Determinar se o epitélio corneano pode impedir ou diminuir o efeito do tratamento com "cross-linking" (CXL). Por meio de microscopia por imunofluorescência, foi indiretamente analisado o efeito do epitélio como escudo aos raios ultravioleta-A (UVA), assim como barreia à penetração da riboflavina. MÉTODOS: Quinze olhos enucleados de porcos foram divididos em 3 grupos. O epitélio corneano foi mantido intacto em todos os grupos. Cinco olhos serviram como controle (Grupo 1). No grupo 2, os olhos foram instilados com colírio anestésico de tetracaína, assim como colírio de riboflavina 0,1 por cento (10 mg de riboflavina-5-fosfato em 10 ml de dextran 20 por cento T-500). No grupo 3, solução de riboflavina foi injetada na câmara anterior para permitir a penetração da droga através do endotélio. Os grupos 2 e 3 foram então expostos à radiação UVA (365 nm, 3 mW/cm²) por 30 minutos. Subsequentemente, cortes ultrafinos (8 µm) das córneas foram marcados com anticolágeno tipo I e DAPI (4,6-diamidino-2-fenilindole dihydrocloride) e analisados com microscópio de imunofluorescência. RESULTADOS: As córneas que receberam injeção intracameral de riboflavina e foram irradiadas com UVA (Grupo 3) mostraram um padrão maior de organização das fibras de colágeno em relação aos grupos 1 (Controle) e 2 (instiladas com colírio anestésico e de riboflavina). Macroscopicamente, a coloração amarelada do estroma, que representa a difusão da riboflavina, foi apenas observada nos olhos que receberam riboflavina intracameral. CONCLUSÃO: Foi demonstrado, através de microscopia por imunofluorescência em córneas de porcos, que o epitélio corneano íntegro diminui a efetividade do CXL por reduzir a penetração da riboflavina, e não por impedir a penetração dos raios UVA. Uma concentração intraestromal inadequada de riboflavina limita o efeito do tratamento.


Asunto(s)
Animales , Epitelio Corneal/efectos de los fármacos , Epitelio Corneal/efectos de la radiación , Fármacos Fotosensibilizantes/farmacocinética , Riboflavina/farmacocinética , Reactivos de Enlaces Cruzados , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo I/efectos de la radiación , Microscopía Fluorescente , Porcinos , Rayos Ultravioleta
9.
Artículo en Inglés | IMSEAR | ID: sea-139987

RESUMEN

Context: Today many materials have been introduced for root-end filling materials. One of them is mineral trioxide aggregate (MTA) that is mentioned as a gold standard. Aims: The purpose of this in vitro study was to evaluate the reaction of human periodontal ligament fibroblasts to the root-end filling materials, such as ProRoot MTA, Portland cement, and amalgam. Settings and Design: Eight impacted teeth were extracted in aseptic condition. The tissues around the roots were used to obtain fibroblast cells. After cell proliferation, they were cultured in the chamber slides and the extracts of the materials were added to the wells. Materials and Methods: Immunocytochemical method for measuring the expression of Fibronectin, collagen I and transforming growth factor beta (TGF®) was performed by Olysia Bioreport Imaging Software. Statistical Analysis Used: The results were analyzed by SPSS 13.0 and Tukey post hoc test with P<0.05 as the limit of significance. Results: Collagen expression in MTA specimens was higher than the other groups in 24 h significantly. After 48 h, the Portland cement group showed the most expression of collagen significantly and after 1 week, Portland cement and MTA groups had the most expression of collagen but there was no significant difference between these 2 groups. After 1 week, the Portland cement group demonstrated a higher amount of TGF® and fibronectin. Conclusions: The results suggest that Portland cement can be used as a less expensive root filling material with low toxicity. It has better effects than amalgam on the fibroblasts.


Asunto(s)
Compuestos de Aluminio/farmacología , Compuestos de Calcio/farmacología , Técnicas de Cultivo de Célula , Células Cultivadas , Colágeno Tipo I/análisis , Colágeno Tipo I/efectos de los fármacos , Colorantes/diagnóstico , Amalgama Dental/farmacología , Cementos Dentales/farmacología , Combinación de Medicamentos , Fibroblastos/efectos de los fármacos , Fibronectinas/análisis , Fibronectinas/efectos de los fármacos , Humanos , Procesamiento de Imagen Asistido por Computador , Inmunohistoquímica , Ensayo de Materiales , Óxidos/farmacología , Ligamento Periodontal/efectos de los fármacos , Obturación Retrógrada , Materiales de Obturación del Conducto Radicular/farmacología , Silicatos/farmacología , Factores de Tiempo , Factor de Crecimiento Transformador beta/análisis , Factor de Crecimiento Transformador beta/efectos de los fármacos
10.
SPJ-Saudi Pharmaceutical Journal. 2005; 13 (1): 34-41
en Inglés | IMEMR | ID: emr-75101

RESUMEN

Several studies have documented the role of angiotensin-converting enzyme inhibitors [ACEI] as antifibrogenic and antiproliferative in different tissues in vivo and in vitro but unfortunately non of them has investigated this effect on collagen synthesis by individual liver cells. In this study we focused on the in vitro effect of two ACEI with different pharmacologic properties, captopril and lisinopril, on the synthesis of types I and III collagens by individual liver cells, since these types of collagens are the most abundant ECM molecules both in normal and fibrotic liver. Rat liver cells were isolated, separated according to cell types through density gradient centrifugation in percoll then cultured as separate clones for 24 hours. Types I and III collagens secretion was measured by gel electrophoresis [SDS-PAGE] and computer analysis of their alpha chains after purification from cell culture media. Both captopril and lisinopril significantly reduced types I and III collagens by cultured hepatocytes [HC], liver endothelial cells [EC], and hepatic stellate cells [HSC] with more prominent action for captopril than lisinopril. The present study document the inhibitory effect of ACEI on types I and III collagen synthesis by liver cell sub-population in vitro by a mechanism independent on the systemic angiotensin-converting enzyme inhibition and possibly through a mechanism involving a local renin-angiotensin system or interference with intracellular events involved in collagen synthesis


Asunto(s)
Animales , Captopril/farmacología , Lisinopril/farmacología , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo III/efectos de los fármacos , Hepatocitos/efectos de los fármacos , Células Endoteliales/efectos de los fármacos , Ratas , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos
11.
Southeast Asian J Trop Med Public Health ; 2002 Sep; 33(3): 654-61
Artículo en Inglés | IMSEAR | ID: sea-34127

RESUMEN

Teeth have been recognized as providing a useful long-term record of lead (Pb2+) uptake. However, information regarding the effects of lead on dental pulp tissue cells that foster dentinogenesis is scarce. This study investigated the effects of lead on dental pulp tissue using human dental pulp fibroblasts in vitro. Dental pulp cells from the teeth of young patients (aged 17-24 years) were cultured and subsequently treated with lead glutamate. It was shown that, in serum-free conditions, all the tested concentrations of lead (4.5 x 10(-5) M, 4.5 x 10(-6) M, and 4.5 x 10(-7) M) significantly increased pulpal cell proliferation. In the presence of 2% fetal bovine serum, increasing cell proliferation was observed only after exposure to a lead concentration of 4.5 x 10(-5) M. However, protein, procollagen type I, and osteocalcin productions were significantly decreased. The alteration of cell population and protein production of affected human dental pulp shown in this study are toxic effects of the lead.


Asunto(s)
Adolescente , Adulto , Análisis de Varianza , División Celular/efectos de los fármacos , Células Cultivadas , Colágeno Tipo I/efectos de los fármacos , Pulpa Dental/citología , Relación Dosis-Respuesta a Droga , Fibroblastos/efectos de los fármacos , Humanos , Plomo/toxicidad , Intoxicación por Plomo/diagnóstico , Osteocalcina/efectos de los fármacos , Biosíntesis de Proteínas , Proteínas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA